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Abstract
Aim: The purpose of the present study was to assess the dietary fat intake, glucose, insulin, Homeostasis model
assessment for insulin resistance HOMA-IR, and endotoxin levels and correlate them with adipokine serum
concentrations in obese adolescents who had been admitted to long-term interdisciplinary weight-loss therapy.
Design: The present study was a longitudinal clinical intervention of interdisciplinary therapy. Adolescents
(n = 18, aged 15–19 y) with a body mass index > 95th percentile were admitted and evaluated at baseline and
again after 1 year of interdisciplinary therapy. We collected blood samples, and IL-6, adiponectin, and endotoxin
concentrations were measured by ELISA. Food intake was measured using 3-day diet records. In addition, we
assessed glucose and insulin levels as well as the homeostasis model assessment for insulin resistance (HOMA-IR).
Results: The most important finding from the present investigation was that the long-term interdisciplinary lifestyle
therapy decreased dietary fat intake and endotoxin levels and improved HOMA-IR. We observed positive
correlations between dietary fat intake and endotoxin levels, insulin levels, and the HOMA-IR. In addition, endotoxin
levels showed positive correlations with IL-6 levels, insulin levels and the HOMA-IR. Interestingly, we observed a
negative correlation between serum adiponectin and both dietary fat intake and endotoxin levels.
Conclusions: The present results indicate an association between dietary fat intake and endotoxin level, which was
highly correlated with a decreased pro-inflammatory state and an improvement in HOMA-IR. In addition, this
benefits effect may be associated with an increased adiponectin level, which suggests that the interdisciplinary
therapy was effective in improving inflammatory pathways.
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Introduction
Saturated and trans fatty acids intake leads to inflamma-
tion, insulin resistance and a gain in body mass. Sys-
temic low-level inflammation has been suggested to be
both a cause and a consequence of comorbidities asso-
ciated with obesity [1,2]. Recently, studies have proposed
that the microbial ecology in humans could be an
important factor in determining energy homeostasis (i.e.,
obesity, diabetes, and fatty liver) [3-9]. Lipopolysacchar-
ide (LPS), which is also referred to as endotoxin, has
been implicated as a potent inducer of inflammation,
and LPS increases tumor necrosis factor alpha (TNF-α)
and interleukin 6 (IL-6) and reduces adiponectin levels.
In normal circumstances, only small amounts of endo-
toxin cross from the intestinal lumen into systemic cir-
culation, and the absorbed endotoxin is rapidly removed
by monocytes, particularly resident Kupffer cells within
the liver. Emerging evidence has indicated that chronic
elevation of serum endotoxin levels may play a role in
insulin-resistant states and obesity [4,5,10].
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Interestingly, some authors described how physical in-
activity leads to the accumulation of visceral fat and the
activation of a network of inflammatory pathways that
promote the development of insulin resistance, athero-
sclerosis, obesity, neurodegeneration, and tumor growth
(i.e., the development of diseases belonging to the “dis-
easome of physical inactivity”) [11,12].
Recently, our group has shown that long-term inter-
disciplinary lifestyle therapy is effective in controlling
the psychological and physiological alterations that are
commonly observed in obese patients [13-21]. Despite
promising results, few studies have addressed the effects
of long-term interdisciplinary intervention on dietary fat
intake and endotoxin levels and their correlation with
insulin resistance and adipokine levels.
Materials and methods
Population
Fifty-four adolescents were invited to participate in a
1-year-long Interdisciplinary Obesity Program at the
Federal University of São Paulo- Paulista Medical School
to promote changes in their sedentary lifestyle and nutri-
tional habits. The basic requirements for participation were
motivation and high attendance at the therapy sessions.
Thirty-nine adolescents participated until the end of the
therapy. The main reasons for dropping out in our study
were financial and family problems, followed by school
and job opportunities. For the present study, we used as
exclusion criteria the lost fat mass < 5% at the end of ther-
apy, where we selected 18 obese adolescents who lost more
than 5% fat mass (the range was 5.4% to 22.5% fat mass).
Selected 18 obese adolescents were evaluated at base-
line and after long-term (1 year) weight loss intervention.
The present study was conducted in accordance with the
principles of the Declaration of Helsinki and was for-
mally approved by the Institutional Ethical Committee
(#0135/04). Informed consent was obtained from all sub-
jects and/or their parents, and the agreement of the ado-
lescents and their families to participate was voluntary.
The ages of the 18 participants ranged from 15–19
years (16.6 ± 1.67 years), and the average body mass index
(BMI) was 37.98 ± 4.60 kg/m2 (7 boys and 11 girls). All
participants met the inclusion criteria of postpubertal
Stage V, based on the Tanner stages [22], and of obesity
(BMI > 95th percentile) according to the Centers for Dis-
ease Control and Prevention (CDC) reference growth
charts. Noninclusion criteria included identifiable gen-
etic, metabolic or endocrine disease or previous drug
utilization [23].
Study protocol and medical screening
Subjects were medically screened, and we assessed their
pubertal stage and recorded their anthropometric mea-
sures (i.e., height, weight, BMI and body composition).
The endocrinologist completed a clinical interview,
which included questions to determine eligibility based
on inclusion and exclusion criteria. Blood samples were
collected and analyzed, and an ultrasound (US) was per-
formed. The procedures were scheduled for the same
time of day for all subjects to remove any influence of
diurnal variations. After the initial screening, obese ado-
lescents started the interdisciplinary weight loss program
(described in a later section).
Anthropometric measurements and body composition
Subjects were weighed on a Filizola scale while wearing
light clothing and no shoes, and their weight was
recorded to the nearest 0.1 kg. Height was measured
using a wall-mounted stadiometer (Sanny, model ES 2030)
to the nearest 0.5 cm. Body mass index was calculated
as body weight (wt) divided by height (h) squared (wt/ht2).
Body composition was estimated by plethysmography
using the BOD POD body composition system (version
1.69, Life Measurement Instruments, Concord, CA),
which is the most advanced technique available for asses-
sing body composition. The patented air displacement
plethysmography used by the BOD POD and PEA POD
is similar in principle to hydrostatic (or "underwater")
weighing. The obvious difference between them is that
air is more convenient and comfortable than water, and
air displacement plethysmography provides a much sim-
pler and safer testing environment, better reliability and
significantly improved repeatability and accuracy [24].
Serum analysis
Blood samples were collected in the outpatient clinic at
approximately 0800 h after an overnight fast. Adipokine
(IL-6 and adiponectin) concentrations were measured
using commercially available ELISA kits from eBioscience,
Inc. (San Diego, CA, USA) and R&D Systems (USA) ac-
cording to the manufacturer’s manuals.
Fasting insulin concentrations were determined using
commercially available ELISA kits from Millipore (Millipore
Corporate Headquarters: 290 Concord Road, Billerica,
MA 01821), and glucose concentrations were determined
by an enzymatic method (LabtestW). Homeostasis model
assessment for insulin resistance (HOMA-IR) was calcu-
lated with assessed values of glucose and insulin.
Measurement of circulating endotoxin levels
Plasma endotoxin was assayed using a chromogenic lim-
ulus amebocyte lysate (LAL) test, which is a quantitative
test for Gram-negative bacterial endotoxin (Cambrex
Corporation, 8830 Biggs Ford Road, Walkersville – USA).
Gram-negative bacterial endotoxin catalyzes the activa-
tion of a proenzyme in the LAL, and the initial rate of ac-
tivation is directly determined by the concentration of
endotoxin. The activated enzyme catalyzes the splitting
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of p-nitroaniline (pNA) from the colorless substrate
Ac-lle-Glu-Ala-Arg-pNA, and the released pNA was
measured photometrically at 405–410 nm following ter-
mination of the reaction. The correlation between the
absorbance and the endotoxin concentration was linear
in the range of 0.1–1.0 EU/ml. For the purposes of this
study, all samples were run in duplicate within the same
plate; therefore, no interassay variability was observed in
this study.
To assess recovery of endotoxin within the assay,
known concentrations of recombinant endotoxin (0.25
and 1.00 EU/ml) were added to diluted plasma to deter-
mine whether the expected concentration correlated
with the actual observed value and whether there were
any variations due to reaction with plasma contents.
Lyophilized endotoxin (E. coli origin) was used to gener-
ate a standard curve with the chromogenic LAL test kit
in accordance with the manufacturer's instructions.
Visceral and subcutaneous adiposity measurements
All abdominal ultrasonographic procedures and mea-
surements of visceral and subcutaneous fat tissue were
performed by the same physician who was blinded to
the subjects’ assignment group. This physician was a
specialist in imaging diagnostics using a 3.5-MHz multi-
frequency transducer (broad band), which reduces the
risk of misclassification. The intra-examination coeffi-
cient of variation for US was 0.8%.
We took US measurements of intra-abdominal (¨vis-
ceral¨) and subcutaneous fat. Ultrasound-determined
subcutaneous fat was defined as the distance between
the skin and external face of the recto abdominis
muscle, and visceral fat was defined as the distance be-
tween the internal face of the same muscle and the an-
terior wall of the aorta. Cutoff points to define visceral
obesity by ultrasonographic parameters were based on
previous methodological descriptions [25].
Clinical intervention
Dietary program
Energy intake was set at the levels recommended by the
dietary reference intake for subjects with low levels of
physical activity of the same age and gender following a
balanced diet as previously described [20]. No drugs or
antioxidants were recommended. Once a week, adoles-
cents had a dietetics lesson, which provided information
on the food pyramid, diet record assessment, weight loss
diets and miracle diets, food labels, dietetics, fat-free and
low-calorie foods, fats (kinds, sources and substitute
foods), fast food calories and nutritional composition,
good nutritional choices in special occasions, healthy
sandwiches, shakes and products to promote weight loss,
functional foods and decisions on food choices. All
patients received individual nutritional consultation
during the intervention program. In addition, a dietitian
encouraged the parents to call if they needed extra
information.
Exercise program
During the one-year interdisciplinary intervention period,
adolescents followed a personalized aerobic training pro-
gram that included a 60-minute session completed three
times each week (180-minute/week) under the supervi-
sion of a sports therapist. Each program was developed
according to the results of an initial oxygen uptake test
for aerobic exercises (cycle-ergometer and treadmill).
The intensity was set at a work load corresponding to a
ventilatory threshold of 1 (50% to 70% of oxygen uptake
test). Adolescents were under heart-rate monitoring dur-
ing the aerobic sessions. The exercise program was based
on the 2009 recommendations of the American College
of Sports Medicine [26].
Psychological intervention
Diagnoses of common psychological problems associated
with obesity, such as depression, disturbances of body
image, anxiety and decreased self-esteem, were estab-
lished by validated questionnaires. During the inter-
disciplinary intervention, the adolescents had weekly
psychological support group sessions. During these ses-
sions, the adolescents discussed body image; alimentary
disorders, including bulimia, anorexia nervosa and binge
eating; the signs, symptoms and health consequences of
these disorders; the relationship between feelings and
food; and family problems, such as alcoholism. Indi-
vidual psychological therapy was recommended if in-
dividuals were found to have nutritional or behavioral
problems [16].
Statistical analysis
The data distribution was checked by Bartlett's test for
equal variances, and the data are reported as the mean ±
SD. Statistical outliers within each treatment group were
identified using Grubbs’ test (GraphPad Software) and
subsequently removed. All remaining data were analyzed
by GraphPad Prism (version 5.00). The differences be-
tween groups for all parameters were assessed by a
paired Student’s t test. The Pearson correlation coeffi-
cient was calculated to assess the relationship between
variables, and all analyses were carried out with the sig-
nificance level set at p < 0.05.
Results
Long-term therapy was effective in reducing body weight
(15%), BMI (15%), percent fat (24%), and fat mass (33%).
These results are shown in Table 1.
Characteristics of the food intake in obese adolescents
are shown in Table 2. Energy intake was reduced 38%,
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carbohydrate intake was reduced 28%, protein intake
was reduced 43%, and fat intake was reduced 47%.
Glucose, insulin, IL-6, adiponectin and endotoxin levels
as well as the HOMA-IR are shown in Table 3. Glucose
(the range before therapy was 4.38 – 5.66 μU/mL, and
the range after therapy was 4.32 – 4.77 μU/mL), insulin
(the range before therapy was 7.10 – 23.3 μU/mL, and the
range after therapy was 5.00 – 18.9 μU/mL), IL-6 (the
range before therapy was 0.97 – 2.22 in Log pg/mL, and
the range after therapy was 0.97 – 2.30 Log in pg/mL),
adiponectin (the range before therapy was 0.78 – 1.14 Log
in ng/mL, and the range after therapy was 0.92 – 1.20 Log
in ng/mL), HOMA-IR (the range before therapy was 1.45
– 5.23 μU/mL, and the range after therapy was 1.01 – 3.87
μU/mL), and endotoxin (the range before therapy was
0.112 – 0.394 in Log EU/mL, and the range after therapy
was 0.095 – 0.309 in Log EU/mL) were reduced after
therapy.
Pearson correlation analyses showed positive correla-
tions between dietary fat intake and endotoxin levels
(r = 0.36, p < 0.01), dietary fat diet intake and insulin
levels (r = 0.38, p < 0.05), and dietary fat intake and
HOMA-IR (r = 0.41, p < 0.04). In addition, there was a
negative correlation between dietary fat intake and adi-
ponectin (r =−0.42, p < 0.01) (Figure 1A-D).
We also observed positive correlations between endo-
toxin and IL-6 levels (r = 0.35, p < 0.03), endotoxin and
insulin levels (r = 0.36, p < 0.05), and endotoxin levels
and HOMA (r = 0.35, p < 0.05). Interestingly, we
observed a negative correlation between endotoxin and
adiponectin levels (r =−0.28, p < 0.06) (Figure 2A-D).
Discussion
The present study showed that long-term therapy was
effective in reducing dietary fat intake and endotoxin
levels. In addition, these data were positively correlated
with improvements in insulin resistance in obese
adolescents.
The chronic endotoxemia, have promoted glucose in-
tolerance and hepatic insulin resistance, suggesting its
role as a link between innate immunity, inflammation,
and insulin resistance [27].
Decreased endotoxin levels have been found with con-
sumption of a low-fat diet compared with a high-fat diet
[28-30]. In addition, the type of fatty acid in the diet
could have important effects on endotoxinemia. Re-
cently, several studies have shown that omega-3 (ω-3)
fatty acids, particularly eicosapentaenoic acid (EPA),
reduces endotoxin and pro-inflammatory cytokine con-
centrations [29,30]. Moreover, Oz et al. [31] demon-
strated that a diet rich in EPA, docosahexaenoic acid
(DHA), and prebiotic fructooligosaccharides (FOS)
protects against LPS-induced systemic inflammatory
responses. In contrast to the present study, Al-Attas
et al. [3] showed that a diet-controlled program in dia-
betic individuals did not significantly decrease endotoxin
levels compared with individuals who only received insu-
lin. Interestingly, herbs used in food dishes reduce the
production of LPS and pro-inflammatory cytokines [32].
In the present study, we observed that interdisciplinary
therapy was able to decrease the fat intake, which least
in part, was sufficient to reduce endotoxin concentra-
tions and insulin resistance. The reduced endotoxin
levels to be related with recovery metabolism and in-
flammation status that leads to anti-inflammatory status.
The present study found a positive correlation be-
tween endotoxin and both pro-inflammatory cytokines
(especially, IL-6) and insulin resistance. After interdis-
ciplinary therapy, endotoxinemia, pro-inflammatory sta-
tus and insulin resistance were decreased. These results
showed the importance of making lifestyle changes (i.e.,
Table 1 Effect of long-term multidisciplinary lifestyle
therapy on body fat (n = 18)
Variables Before After % Change p Value
Age (yrs) 15 ± 1.73 16 ± 0.63 7 0.11
Body weight (kg) 106.49 ± 11.25 90.53 ± 10.98 −15 <0.001
Fat mass (kg) 49.6 ± 10.1 32.9 ± 12.3 −33 <0.001
Fat-free mass (kg) 55.8 ± 7.49 58.1 ± 7.71 +4 0.19
BMI (kg/m2) 37.98 ± 4.60 32.31 ± 4.44 −15 <0.001
Percent fat (%) 47.50 ± 6.99 35.81 ± 9.60 −24 <0.001
Results are expressed as mean value ± SD.
Table 2 Characteristics of the food intake in obese
adolescents
Variables Baseline After 1 year
Energy intake (kcal) 1988.04 ± 632.91 1226.77 ± 392.66*
Carbohydrate (g) 235.34 ± 92.24 169.54 ± 47.35*
Carbohydrate (%) 49.48 ± 7.04 58.39 ± 14.30*
Protein (g) 94.42 ± 36.98 53.08 ± 18.58*
Protein (%) 18.58 ± 4.33 17.32 ± 3.83
Lipids (g) 71.75 ± 29.91 37.72 ± 19.28*
Lipid (%) 32.03 ± 4.63 26.20 ± 7.9*
* After 1 year vs. Baseline data p≤ 0.01.
Table 3 Glucose, insulin, HOMA index and endotoxin
levels in obese adolescents (n =18)
Parameters Before After % Change p Value
Glucose (μU/mL) 4.91 ± 0.41 4.55 ± 0.12 −7.2 0.02
Insulin (ng/mL) 17.45 ± 4.86 10.21 ± 4.33 - 41 0.001
HOMA index 3.82 ± 1.11 2.07 ± 0.91 - 45 0.002
IL-6 (Log- pg/mL) 1.63 ± 0.38 1.53 ± 0.33 - 7 0.06
Endotoxin (Log- EU/mL) 0.237 ± 0.06 0.188± 0.04 - 21 0.0003
Adiponectin (Log- ng/mL) 0.979 ± 0.09 1.092± 0.07 +12 0.001
Results are expressed as mean value ± SD.
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nutritional modification) to reduce the pro-inflammatory
state in obese individuals. We have previously shown
that long-term therapy is effective in reducing body fat
(especially visceral fat), TNF-α and IL-6 and increasing
IL-10 and adiponectin. In addition, we observed a posi-
tive correlation between pro-inflammatory cytokines (IL-
6 and TNF-α levels) and visceral fat [20]. In addition,
we can suggested a significant improvement of inflam-
matory profile once adiponectin, the anti-inflammatory
adipokine, increased significantly after the long-term in-
tervention (12%) and reduction of HOMA-IR, an index
that present association to inflammatory pathways, such
as increase of IL-6 and TNF-alpha.
Creely et al. [5] found that circulating serum endo-
toxin was higher in type 2 diabetes mellitus (T2DM)
patients than in lean healthy subjects, and endotoxin
can activate the innate immune pathway in isolated
abdominal adipocytes to stimulate secretion of pro-
Figure 1 A-D Correlation Pearson between of fat diet intake and endotoxin, insulin, adiponectin and HOMA level in obese adolescents
(n = 18).
Figure 2 A-D Correlation Pearson between of endotoxin and IL-6, insulin, adiponectin and HOMA level in obese adolescents (n = 18).
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inflammatory cytokines. Creely et al. [5] suggested that
the subclinical inflammation seen in type 2 diabetes pa-
tients was related to the increase in endotoxin. Mehta
et al. [33] observed that endotoxemia (3 ng/kg intraven-
ous bolus in healthy adults) induced an elevation in
TNF-α and systemic insulin resistance in humans. Fur-
thermore, insulin resistance measured at 24 h post-LPS
was preceded by specific modulation of adipose inflam-
matory and insulin signaling pathways. Leuwer et al. [34]
have shown that endotoxemia leads to major increases in
inflammatory adipokine (TNF-α, IL-6, and MCP-1) gene
expression in white adipose tissue in mice. In addition,
previous studies in human adipose tissue have shown
that obesity and T2DM induce upregulation of inflam-
matory genes [5]. These results are in agreement with
the present study in which endotoxin showed a close cor-
relation with IL-6, which was reduced after 1 year of
interdisciplinary therapy.
Although we did not directly analyze the effect of ex-
ercise, we cannot exclude that the exercise protocol used
in the present study contributed to the beneficial effects
of the interdisciplinary therapy in obese adolescents.
Many studies [11,35-37] have actually demonstrated the
benefits of exercise training, which induces an anti-
inflammatory state in obese rat and human models.
Bradley et al. [36] suggested that voluntary exercise in
diet-induced obese mice reduced adiposity despite con-
tinued consumption of a high-fat diet. In addition, exer-
cise normalized insulin sensitivity and decreased adipose
tissue inflammation (reduced IKK-β gene expression) in
these obese mice. These data demonstrated the posi-
tive role of exercise training in preventing the develop-
ment of several diseases, including obesity, diabetes,
and fatty liver.
Starkie et al. [38] demonstrated that an intravenous
infusion of endotoxin induced a two to threefold in-
crease in the plasma TNF-α level. When human sub-
jects adopted an acute exercise protocol (75% VO2max),
however, the production of TNF-α elicited by low-
grade endotoxemia was inhibited. Similarly, Chen et al.
[39] found that chronically exercised rats exhibited
minor pathological changes in the heart, liver, and lung
after endotoxemia. In addition, Lira et al. [40] ob-
served that a lifestyle change associated with high-in-
tensity, high-volume exercise induced favorable changes
in chronic low-grade inflammatory markers and may
reduce the risk for obesity, diabetes and cardiovascular
diseases.
Although the small number of participants could be a
limitation of the present study, the results contribute to
the understanding of the mechanisms linking insulin re-
sistance, adiponectinemia in obesity and endotoxemia to
the inflammatory state. In addition, the present study
highlights the importance of lifestyle interdisciplinary
therapy intervention as clinical practice for obesity
treatment.
In summary, the present study demonstrated an im-
portant association between dietary fat intake and endo-
toxin level, which reduced significantly after the long-
term intervention. Indeed, based on these data, we can
hypothesize a link between dietary fat intake, insulin re-
sistance, endotoxin and inflammatory pathways.. Taken
together, these results suggest that interdisciplinary
therapy is effective in decreasing inflammatory markers
related to obesity.
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